Corporate News     29-May-24
Samvardhana Motherson International approves NCD issuance of Rs 5000 cr
The Board of Samvardhana Motherson International at its meeting held on 29 May 2024 has approved raising of funds by way of issuance of non-convertible debentures of face value of Rs 1 lakh each aggregating to Rs 5000 crore on private placement basis in one or more tranches.
Previous News
  Samvardhana Motherson International get NCDs rated
 ( Corporate News - 19-Jun-25   12:26 )
  Samvardhana Motherson International Ltd down for fifth straight session
 ( Hot Pursuit - 18-Jun-25   13:35 )
  Samvardhana Motherson Intl. to conduct board meeting
 ( Corporate News - 17-Jun-25   10:21 )
  Samvardhana Motherson Intl. AGM scheduled
 ( Corporate News - 30-May-25   13:02 )
  Samvardhana Motherson International consolidated net profit declines 23.42% in the March 2025 quarter
 ( Results - Announcements 29-May-25   17:30 )
  Board of Samvardhana Motherson Intl. recommends final dividend
 ( Corporate News - 29-May-25   17:27 )
  Board of Samvardhana Motherson International approves bonus issue of 1:2
 ( Corporate News - 29-May-25   15:59 )
  Board of Samvardhana Motherson International approves NCD issuance up to Rs 8,500 cr
 ( Corporate News - 29-May-25   15:06 )
  Samvardhana Motherson International fixes record date for final dividend
 ( Market Beat - Reports 29-May-25   14:56 )
  Samvardhana Motherson Intl. schedules board meeting
 ( Corporate News - 16-May-25   17:02 )
  Samvardhana Motherson International Ltd Surges 8.04%, BSE Auto index Gains 2.72%
 ( Hot Pursuit - 15-Apr-25   09:30 )
Other Stories
  LMW schedules board meeting
  03-Jul-25   09:15
  Julien Agro Infratech announces board meeting date
  03-Jul-25   09:15
  Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
  03-Jul-25   09:15
  Shriram Asset Mgt. Company schedules AGM
  03-Jul-25   09:14
  Ideaforge Technology to convene AGM
  03-Jul-25   09:14
  D-Link (India) to announce Quarterly Result
  03-Jul-25   09:14
  Tuni Textile Mills to conduct board meeting
  03-Jul-25   09:14
  Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
  03-Jul-25   09:12
  Shakti Pumps launches QIP issue
  03-Jul-25   09:08
  Jai Mata Glass to conduct board meeting
  02-Jul-25   19:12
Back Top